Sign in

Lost your password?

Shire Deutschland

Last updated: 13.02.2014

Address: Friedrichstraße 149, 10117 Berlin,Germany

Tel: 0049 (0) 30 206 582 – 0


Company description

Founded in 1986, Shire is a fast-growing global specialty biopharmaceutical company with 2008 revenues of $3 billion and over 3,500 employees worldwide. A global leader working to meet the needs of the specialist physician and the patients they serve, Shire today has a presence in 23 countries and medicines available in nearly 40 countries.

Shire’s operation is structured in two complementary businesses – Human Genetic Therapies (HGT), and Specialty Pharmaceuticals – that are each supported by various corporate functions. The HGT team specializes in researching, developing, and commercializing therapies for the treatment of rare genetic diseases caused by protein deficiencies. Shire’s Specialty Pharmaceuticals team is made up currently of three business units – ADHD, GI, and Emerging Products. This team also oversees many other marketed medicines approved to help people around the world.

Products and services

Shire focuses on the therapeutic areas of attention deficit and hyperactivity disorder (ADHD), gastrointestinal (GI), and genetic disorders.



We use cookies to ensure that we give you the best experience on our site. For more info click here